(Q74611871)
Statements
Octreotide acetate long-acting formulation versus open-label subcutaneous octreotide acetate in malignant carcinoid syndrome (English)
J Rubin
J Ajani
W Schirmer
A P Venook
R Bukowski
R Pommier
L Saltz
P Dandona
1 February 1999